A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...
A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by recommending insulin-dose ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...
Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
The AACE released the 2026 update to its algorithm for the management of adults with type 2 diabetes. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results